Monographie - Omeprazole sodium - Stabilis 4.0

Zadnji put ažurirano :
23/04/2025

Inhibitori protonske pumpe

Omeprazole sodium

injekcija

oralna otopina

Stabilizacija rješenja

Stabilnost mješavine

Stabilizacijski faktor

Kompatibilnosti

način davanja lijeka

Bibliografija

pdf

Kemijska struktura

Nekomercijalni

Nekomercijalni

Zaštićeni nazivi su indikativni i sastav ekscipijensa može biti različit ovisno o državi i laboratorijima

Biomezol	Ekvador
Cezole	Peru
Dinsadrix	Meksiko
Finulcer	Meksiko
Fordex	Venecuela
Gastromax	Venecuela
Haitrax	Meksiko
Imaroz	Čile
Inhibitron	Meksiko
Ipproton	Saudijska Arabija, Tunis
Klomeprax	Argentina, Ekvador
Losec	Austrija, Egipat, Ekvador, Grčka, Hrvatska, Kolumbija, Meksiko, Nizozemska, Poljska, Portugal, Saudijska Arabija, Švedska, Ujedinjeni Arapski Emirati
Omeprazole	Francuska
Oprazole	Saudijska Arabija
Penrazol	Malezija
Timezol	Argentina
Ulcozol	Argentina, Ekvador
Ultop	Rumunjska

Bibliografija

injekcija

Bibliografija : Omeprazole sodium

	Vrsta	Publikacija
186	Časopis	Swart EL, Mooren RAG, Van Loenen AC. Compatibility of midazolam hydrochloride and lorazepam with selected drugs during simulated Y-site administration. Am J Health-Syst Pharm 1995 ; 52: 2020-2022.
264	Časopis	Leboucher G, Charpiat B. Incompatibilité physico-chimique entre l’oméprazole et la vancomycine. Pharm Hosp Fr 1997 ; 121: 124.
1703	Časopis	Schuster F, Bernard R. Kompatibilität von enalaprilat i.v. mit ausgewählten arzneimitteln. Krankenhauspharmazie 1995 ; 16: 101-103.
2231	Časopis	de Jongh R, Hens R, Basma V, mouton JW, Tulkens PM, Carryn S. Continuous versus intermittent infusion of temocillin, a directed spectrum penicillin for intensive care patients with nosocomial pneumonia: stability, compatibility, population pharmacokinetic studies and breakpoint selection. J Antimicrob Chemother 2008 ; 61, 2: 382-388.
2311	Časopis	Kambia N.K, Luyckx M, Dine T, Dupin-Spriet T, Gressier B, Brunet C. Nefopam hydrochloride compatibility and stability with selected proton pump inhibitors in bionolyte G5 injection for intravenous infusion. J Clin Pharm Ther 2009 ; 34: 25-31.
3332	Laboratorija	Tigecycline (Tigacyl®) - Summary of Product characteristics Pfizer 2012
3658	Laboratorija	Omeprazole - Summary of Product Characteristics. Sandoz 2014
3823	Časopis	Juan E.P, Palau M.M, Cerd? S.A, Rubert M.A, Nicolau B.R. Compatibilité physique de médicaments administrés dans l’unité de soins intensifs Pharmactuel 2015 ; 48, 3 : 146-152.
3871	Plakat	Soussi M.A, Soualah-alila R, jenene F, Lazreg O, Razgallah Khrouf M. Peut-on administrer le céfotaxime en Y avec d'autres médicaments injectables ? Synprefh Congress Clermont Ferrand, France 2016
3976	Časopis	Du Repaire T, Vigne P, Guedon A, Gauthier-Villano L, Bertault Peres P, Pourroy B. Visual compatibility of blinatumomab with selected co-administrated drugs during simulated Y-site administration. Am J Health-Syst Pharm 2017 ; 74,16 : 1217-1218
3985	Plakat	Manai M., Soussi M.A., Lazreg O., Drira C., Ben Tekaya S. et Razgallah Khrouf M. Compatibilité physique entre médicaments injectables et nutrition parentérale pédiatrique : Evaluation in-vitro. Hopipharm Congress 2017 - Nancy 2017
4316	Časopis	Carpenter J.F, McNulty M-A, Dusci L.J, Ilett K.F. Stability of Omeprazole Sodium and Pantoprazole Sodium Diluted for Intravenous Infusion. J Pharm Technol 2006 ;22:95-98.
4642	Plakat	Larossa garcia M, Jimenez-Lozano I, Boix-Montanés A, Mallandrich Miret M, Clemente Bautista M, cabanas Poy M.J., Gorgas Torner Compatibilidad en Y de atosiban y farmacois habitualmente utilizados en obstetricia. SEFH Congress (Virtual) October 2021 2021

Mentions Légales